Related Experiment Video
Updated: May 15, 2026

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
Published on: July 5, 2017
[Expression and function of ICOS on CD4 T cells and application to therapy in patients with ocular Behçet's disease
1Department of Ophthalmology, Tokyo Medical University, Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. usuyoshi@gmail.com
Uveitis in Behçet's disease (BD) is an important cause of vision loss through recurrent ocular inflammatory attacks. CD4 T cells that react to various self-antigens play a central role in the pathogenesis of this disease, and the activation or inactivation of the CD4 T cells is controlled by costimulatory molecules. In Behçet's disease patients with active uveitis, among the various costimulatory molecules, the inducible costimulator (ICOS), an active form of stimulatory molecule, is most strongly expressed, and is associated with cytokine production by Th1 and Th17 cells. It is suggested that ICOS could be a potential marker of disease activity and a candidate therapeutic target. Inhibition of the ICOS/B7RP-1 costimulatory pathway has demonstrated favorable therapeutic effects in various autoimmune diseases. Targeting the ICOS/ B7RP-1 costimulatory pathway may be a useful future treatment strategy for uveitis in Behçet's disease.
Uveitis in Behçet's disease (BD) is an important cause of vision loss through recurrent ocular inflammatory attacks. CD4 T cells that react to various self-antigens play a central role in the pathogenesis of this disease, and the activation or inactivation of the CD4 T cells is controlled by costimulatory molecules. In Behçet's disease patients with active uveitis, among the various costimulatory molecules, the inducible costimulator (ICOS), an active form of stimulatory molecule, is most strongly expressed, and is associated with cytokine production by Th1 and Th17 cells. It is suggested that ICOS could be a potential marker of disease activity and a candidate therapeutic target. Inhibition of the ICOS/B7RP-1 costimulatory pathway has demonstrated favorable therapeutic effects in various autoimmune diseases. Targeting the ICOS/ B7RP-1 costimulatory pathway may be a useful future treatment strategy for uveitis in Behçet's disease.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
